Medium impact
Left Atrial Appendage and Cardiac Structural Defect Closure - Medicare Advantage (Revised)
Humana·Effective Feb 2, 2026
HCPCS C1817 is officially defined as "Septal defect implant system, intracardiac." HCPCS C1817 is referenced in 1 tracked payer policy change from Humana. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS C1817 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.